Effectiveness and Safety of Apatinib for the Patients With Advanced Soft Tissue Sarcoma

Trial Profile

Effectiveness and Safety of Apatinib for the Patients With Advanced Soft Tissue Sarcoma

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs Apatinib (Primary)
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Sep 2017 Results (n=6) assessing efficacy and safety, presented at the 42nd European Society for Medical Oncology Congress.
    • 03 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top